- Home
- ASRV vs CTSO Comparison
ASRV vs CTSO Comparison
Compare ASRV & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- CTSO
- Stock Information
- Founded
- ASRV 1983
- CTSO 1997
- Country
- ASRV United States
- CTSO United States
- Employees
- ASRV N/A
- CTSO N/A
- Industry
- ASRV Major Banks
- CTSO Medical/Dental Instruments
- Sector
- ASRV Finance
- CTSO Health Care
- Exchange
- ASRV Nasdaq
- CTSO Nasdaq
- Market Cap
- ASRV 51.0M
- CTSO 65.7M
- IPO Year
- ASRV N/A
- CTSO N/A
- Fundamental
- Price
- ASRV $2.80
- CTSO $0.92
- Analyst Decision
- ASRV
- CTSO Buy
- Analyst Count
- ASRV 0
- CTSO 2
- Target Price
- ASRV N/A
- CTSO $5.50
- AVG Volume (30 Days)
- ASRV 29.0K
- CTSO 93.3K
- Earning Date
- ASRV 07-22-2025
- CTSO 08-07-2025
- Dividend Yield
- ASRV 4.20%
- CTSO N/A
- EPS Growth
- ASRV N/A
- CTSO N/A
- EPS
- ASRV 0.22
- CTSO N/A
- Revenue
- ASRV $51,581,000.00
- CTSO $35,332,238.00
- Revenue This Year
- ASRV N/A
- CTSO $11.15
- Revenue Next Year
- ASRV N/A
- CTSO $21.39
- P/E Ratio
- ASRV $12.88
- CTSO N/A
- Revenue Growth
- ASRV 13.95
- CTSO 15.37
- 52 Week Low
- ASRV $2.03
- CTSO $0.71
- 52 Week High
- ASRV $3.42
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- ASRV 36.74
- CTSO 38.65
- Support Level
- ASRV $2.73
- CTSO $0.91
- Resistance Level
- ASRV $2.99
- CTSO $1.06
- Average True Range (ATR)
- ASRV 0.15
- CTSO 0.06
- MACD
- ASRV -0.05
- CTSO -0.02
- Stochastic Oscillator
- ASRV 11.86
- CTSO 4.02
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.